Healthcare & Medical Investment Corporation (TYO:3455)
Japan · Delayed Price · Currency is JPY 117,900
+500 (0.43%)
At close: Sep 26, 2025
TYO:3455 Income Statement
Financials in millions JPY. Fiscal year is February - January.
Millions JPY. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '25 Jul 31, 2025 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | 2016 - 2020 |
Rental Revenue | 5,066 | 5,036 | 4,877 | 4,799 | 4,153 | 4,081 | Upgrade |
Gain (Loss) on Sale of Assets (Rev) | - | - | - | 204.65 | - | - | Upgrade |
Gain (Loss) on Sale of Investments (Rev) | 4.75 | 1.53 | - | - | - | - | Upgrade |
Other Revenue | - | - | 0 | 0 | - | - | Upgrade |
| 5,071 | 5,037 | 4,877 | 5,003 | 4,153 | 4,081 | Upgrade | |
Revenue Growth (YoY | 2.38% | 3.29% | -2.53% | 20.48% | 1.76% | 1.49% | Upgrade |
Property Expenses | 2,332 | 2,288 | 2,193 | 2,106 | 1,789 | 1,727 | Upgrade |
Selling, General & Administrative | 49.28 | 48.19 | 44.67 | 57.6 | 56 | 55 | Upgrade |
Other Operating Expenses | 129.25 | 128.72 | 117.14 | 120.32 | 156 | 159 | Upgrade |
Total Operating Expenses | 2,511 | 2,465 | 2,354 | 2,284 | 2,001 | 1,941 | Upgrade |
Operating Income | 2,560 | 2,572 | 2,523 | 2,719 | 2,152 | 2,140 | Upgrade |
Interest Expense | -386.34 | -353.75 | -277.71 | -213.07 | -300 | -297 | Upgrade |
Interest & Investment Income | 1.41 | 0.29 | 0.15 | 0.09 | - | - | Upgrade |
Other Non-Operating Income | -133.49 | -139.31 | -128.13 | -128.15 | -6 | -4 | Upgrade |
EBT Excluding Unusual Items | 2,041 | 2,079 | 2,117 | 2,378 | 1,846 | 1,839 | Upgrade |
Total Insurance Settlements | 2.05 | 1.77 | 2.34 | 1.82 | - | - | Upgrade |
Other Unusual Items | - | - | - | - | -12 | -12 | Upgrade |
Pretax Income | 2,043 | 2,081 | 2,119 | 2,380 | 1,834 | 1,827 | Upgrade |
Income Tax Expense | 1.78 | 1.81 | 1.76 | 1.63 | - | - | Upgrade |
Net Income | 2,042 | 2,079 | 2,117 | 2,379 | 1,834 | 1,827 | Upgrade |
Net Income to Common | 2,042 | 2,079 | 2,117 | 2,379 | 1,834 | 1,827 | Upgrade |
Net Income Growth | -2.98% | -1.79% | -10.98% | 29.69% | 0.38% | -8.14% | Upgrade |
Basic Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade |
Diluted Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade |
Shares Change (YoY) | - | - | 0.05% | 15.54% | - | 0.13% | Upgrade |
EPS (Basic) | 5679.09 | 5784.27 | 5889.94 | 6619.45 | 5897.09 | 5874.58 | Upgrade |
EPS (Diluted) | 5679.09 | 5784.27 | 5889.94 | 6619.45 | 5897.09 | 5874.58 | Upgrade |
EPS Growth | -2.98% | -1.79% | -11.02% | 12.25% | 0.38% | -8.26% | Upgrade |
Dividend Per Share | 6347.000 | 6444.000 | 6517.000 | 6924.000 | - | - | Upgrade |
Dividend Growth | -2.29% | -1.12% | -5.88% | - | - | - | Upgrade |
Operating Margin | 50.48% | 51.06% | 51.72% | 54.35% | 51.82% | 52.44% | Upgrade |
Profit Margin | 40.26% | 41.28% | 43.42% | 47.54% | 44.16% | 44.77% | Upgrade |
EBITDA | 3,762 | 3,761 | 3,649 | 3,835 | 3,120 | 3,073 | Upgrade |
EBITDA Margin | 74.20% | 74.66% | 74.83% | 76.65% | 75.13% | 75.30% | Upgrade |
D&A For Ebitda | 1,203 | 1,188 | 1,127 | 1,116 | 968 | 933 | Upgrade |
EBIT | 2,560 | 2,572 | 2,523 | 2,719 | 2,152 | 2,140 | Upgrade |
EBIT Margin | 50.48% | 51.06% | 51.72% | 54.35% | 51.82% | 52.44% | Upgrade |
Funds From Operations (FFO) | 1,622 | 3,266 | 3,243 | 3,289 | - | - | Upgrade |
Adjusted Funds From Operations (AFFO) | - | 3,266 | 3,243 | 3,289 | - | - | Upgrade |
FFO Payout Ratio | 142.83% | 71.49% | 75.77% | 67.42% | - | - | Upgrade |
Effective Tax Rate | 0.09% | 0.09% | 0.08% | 0.07% | - | - | Upgrade |
Revenue as Reported | 5,071 | 5,037 | 4,877 | 5,003 | - | - | Upgrade |
Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.